Kite Pharma, Inc.
Kite Pharma, Inc., a leading biotechnology company headquartered in the United States, is at the forefront of cell therapy innovation. Founded in 2009, Kite has made significant strides in the development of chimeric antigen receptor (CAR) T-cell therapies, primarily targeting cancer treatment. With a strong operational presence across North America and Europe, the company focuses on harnessing the power of the immune system to combat malignancies.
Kite's flagship products, including Yescarta, are distinguished by their ability to provide personalised treatment options for patients with certain types of blood cancers. The company has achieved notable recognition within the industry, establishing itself as a pioneer in the field of oncology. With a commitment to advancing cell therapy, Kite Pharma continues to shape the future of cancer treatment, positioning itself as a key player in the biopharmaceutical landscape.
+16 vs industry average
Kite Pharma, Inc.’s score of 54 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Kite Pharma, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Kite Pharma, Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Kite Pharma, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Kite Pharma, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from Gilead Sciences, Inc.
Carbon Disclosure Project
Inherited from Gilead Sciences, Inc.
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Inherited from Gilead Sciences, Inc.
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Kite Pharma, Inc.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project